Expansion of HIV/AIDS, STI and TB Laboratory Activities in the Namibia Institute of Pathology (NIP), Ltd under the President’s Emergency Plan for AIDS Relief (PEPFAR)

Funding Opportunity Number: CDC-RFA-PS09-955SUPP16 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.067Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDCClosing Date: Feb 29, 2016Award Ceiling: $0Expected Number of Awards: 1Creation Date: Jan 04, 2016Funding Opportunity Description: Eligible applicants that can apply for this funding opportunity appear below: • Namibia Institute of Pathology Under the leadership of the U.S. Global AIDS Coordinator, as part of the President's Emergency Plan, the U.S. Department of Health and Human Services’ Centers for Disease Control and Prevention (HHS/CDC) works with host countries and other key partners to assess the needs of each country and design a customized program of assistance that fits within the host nation's strategic plan. HHS/CDC focuses on two or three major program areas in each country. Goals and priorities include the following: • Achieving primary prevention of HIV infection through activities such as expanding confidential counseling and testing programs and building programs to reduce mother-tochild transmission; • Improving the care and treatment of HIV/AIDS, sexually transmitted infections (STIs) and related opportunistic infections by improving STI management; enhancing the care and treatme...
Source: Grants.gov - Category: Research Tags: Health Source Type: funding